Concepedia

Jacob P. Laubach

JP

Statistics

Publications

152

Citations

13.2K

H-Index

52

Active since

1996

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Emory University

Janssen (United States)

Jacob P. Laubach is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top concepts

MedicineOncologyHematologyImmunologyHealthRadiation OncologyImmunotherapyClinical TrialsPharmacotherapyPathology

Publications per year

1996–2025

152

Publications

152

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia

Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · New England Journal of Medicine · 2015 · 913 citations · Full text

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey et al. · Blood · 2009 · 866 citations · Full text

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial

Peter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach et al. · Blood · 2020 · 653 citations · Full text

Rows per page

1–5 of 152